Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - February 2004

  1. HHS-CDC NEWS: Racial/Ethnic Disparities in Influenza and Pneumococcal Vaccination Levels Among Persons Aged >65 Years--United States, 1989-2001. Ann.Pharmacother. 38 (1): 195; January, 2004.

  2. Measles Outbreak Associated With an Imported Case in an Infant--Alabama, 2002. MMWR Morb.Mortal.Wkly.Rep. 53 (2): 30-33; January 23, 2004.

  3. Measles Mortality Reduction--West Africa, 1996-2002. MMWR Morb.Mortal.Wkly.Rep. 53 (2): 28-30; January 23, 2004.

  4. Recommended Childhood and Adolescent Immunization Schedule--United States, January-June 2004.   MMWR Morb.Mortal.Wkly.Rep. 53 (1): Q1-Q4; January 16, 2004.

  5. Allen, U. Reply to Measles Vaccination in Canada. J.Pediatr. 144 (1): 141; January, 2004.

  6. Augey, F.; Legoff, D.; Chouvet, B. [Bullous Eruption After Influenza Virus Vaccination]. Ann.Dermatol.Venereol. 130 (11): 1058-1060; November, 2003.

  7. Breen, D. Pneumococcal Vaccination Programme in Over 65s and at-Risk Groups: the Dumfries and Galloway Experience. Commun.Dis.Public Health. 6 (3): 228-230; September, 2003.

  8. Cardenosa, N.; Dominguez, A.; Martinez, A.; Alvarez, J.; Panella, H.; Godoy, P.; Minguell, S.; Camps, N.; Vazquez, J. A. Meningococcal Disease in Catalonia 1 Year After Mass Vaccination Campaign With Meningococcal Group C Polysaccharide Vaccine. Infection. 31 (6): 392-397; December, 2003.

  9. Chowdhury, A. M.; Bhuiya, A.; Mahmud, S.; Abdus Salam, A. K.; Karim, F. Immunization Divide: Who Do Get Vaccinated in Bangladesh?   J.Health Popul.Nutr. 21 (3): 193-204; September, 2003.

  10. Cooper, B. W. Smallpox Vaccination Risks and Public Policy. Ann.Intern.Med. 140 (1): 67; January 6, 2004.

  11. Cox, R. J.; Brokstad, K. A.; Ogra, P. Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines. Scand.J.Immunol. 59 (1): 1-15; January, 2004.

  12. D'Heilly, S. J.; Lockman, J. L.; Nichol, K. L. Adherence of Mass Vaccinators to Timing Guidelines for Influenza Vaccination. Am.J.Prev.Med. 26 (1): 46-50; January, 2004.

  13. Daley, M. F.; Barrow, J.; Pearson, K.; Crane, L. A.; Gao, D.; Stevenson, J. M.; Berman, S.; Kempe, A. Identification and Recall of Children With Chronic Medical Conditions for Influenza Vaccination. Pediatrics. 113 (1 Pt 1): e26-e33; January, 2004.

  14. Davies, P.; Nwokoro, C.; Leigh, M. Vaccinations Against Influenza and Pneumococcus in Children With Diabetes: Telephone Questionnaire Survey. BMJ. 328 (7433): 203; January 24, 2004.

  15. Deshpande, S. A. Ethnic Differences in the Rates of BCG Vaccination. Arch.Dis.Child. 89 (1): 48-49; January, 2004.

  16. Fedson, D. S. Vaccination for Pandemic Influenza: a Six Point Agenda for Interpandemic Years. Pediatr.Infect.Dis.J. 23 (1): S74-S77; January, 2004.

  17. Filipovic, T.; Grzetic, R.; Sviderek-Stalekar, D. Earlier Detection of Amblyopia and Strabismus by Ophthalmologic Screening Card Attached to the Vaccination Card. Can.J.Ophthalmol. 38 (7): 587-592; December, 2003.

  18. Frick, K. D.; Colchero, M. A.; Dean, D. Modeling the Economic Net Benefit of a Potential Vaccination Program Against Ocular Infection With Chlamydia Trachomatis. Vaccine. 22 (5-6): 690-697; January 26, 2004.

  19. Ginsberg, G. M.; Somekh, E. Cost Containment Analysis of Childhood Vaccination Against Varicella in Israel. J.Infect. 48 (2): 119-133; February, 2004.

  20. Halliday, L.; Thomson, J. A.; Roberts, L.; Bowen, S.; Mead, C. Influenza Vaccination of Staff in Aged Care Facilities in the ACT: How Can We Improve the Uptake of Influenza Vaccine? Aust.N.Z.J.Public Health. 27 (1): 70-75; 2003.

  21. Hammerschmidt, T.; Banz, K.; Wagenpfeil, S.; Neiss, A.; Wutzler, P. Economic Evaluation of Varicella Vaccination Programmes: a Review of the Literature. Pharmacoeconomics. 22 (2): 133-138; 2004.

  22. Henke, A.; Jarasch, N.; Wutzler, P.  Vaccination Procedures Against Coxsackievirus-Induced Heart Disease. Expert.Rev.Vaccines. 2 (6): 805-815; December, 2003.

  23. Jokhdar, H.; Borrow, R.; Sultan, A.; Adi, M.; Riley, C.; Fuller, E.; Baxter, D. Immunologic Hyporesponsiveness to Serogroup C but Not Serogroup A Following Repeated Meningococcal A/C Polysaccharide Vaccination in Saudi Arabia. Clin.Diagn.Lab Immunol. 11 (1): 83-88; January, 2004.

  24. Katz, S. L. Measles Vaccination in Canada. J.Pediatr. 144 (1): 141; January, 2004.

  25. Kermode, M.; Yong, K.; Hurley, S.; Marmion, B. An Economic Evaluation of Increased Uptake in Q Fever Vaccination Among Meat and Agricultural Industry Workers Following Implementation of the National Q Fever Management Program. Aust.N.Z.J.Public Health. 27 (4): 390-398; 2003.

  26. Kissam, S.; Gifford, D. R.; Patry, G.; Bratzler, W. Is Signed Consent for Influenza or Pneumococcal Polysaccharide Vaccination Required?   Arch.Intern.Med. 164 (1): 13-16; January 12, 2004.

  27. Kuno, G. Serodiagnosis of Flaviviral Infections and Vaccinations in Humans. Adv.Virus Res. 61:3-65; 2003.

  28. Lajeunesse, M. An Overview of Vaccination Against Infectious Disease in Children in 2003. Expert.Rev.Vaccines. 2 (5): 611-614; October, 2003.

  29. Lawrence, G. L.; MacIntyre, C. R.; Hull, B. P.; McIntyre, P. B. Measles Vaccination Coverage Among Five-Year-Old Children: Implications for Disease Elimination in Australia. Aust.N.Z.J.Public Health. 27 (4): 413-418; 2003.

  30. Lindholm, C.; Naylor, A.; Johansson, E. L.; Quiding-Jarbrink, M. Mucosal Vaccination Increases Endothelial Expression of Mucosal Addressin Cell Adhesion Molecule 1 in the Human Gastrointestinal Tract. Infect.Immun. 72 (2): 1004-1009; February, 2004.

  31. McVernon, J.; Morgan, P.; Mallaghan, C.; Biswas, T.; Natarajan, M.; Griffiths, D.; Slack, M.; Moxon, R. Outbreak of Haemophilus Influenzae Type b Disease Among Fully Vaccinated Children in a Day-Care Center. Pediatr.Infect.Dis.J. 23 (1): 38-41; January, 2004.

  32. McVernon, J.; Mitchison, N. A.; Moxon, E. R. T Helper Cells and Efficacy of Haemophilus Influenzae Type b Conjugate Vaccination. Lancet Infect.Dis. 4 (1): 40-43; January, 2004.

  33. Meltzer, M. I. Risks and Benefits of Preexposure and Postexposure Smallpox Vaccination. Emerg.Infect.Dis. 9 (11): 1363-1370; November, 2003.

  34. Meyers, D. G. Could Influenza Vaccination Prevent Myocardial Infarction, Stroke and Sudden Cardiac Death? Am.J.Cardiovasc.Drugs. 3 (4): 241-244; 2003.

  35. Milani, V.; Endres, M.; Kuppner, M. C.; Issels, R. D.; Noessner, E. [Heat Shock Proteins, Immune Competence and Vaccination]. Dtsch.Med.Wochenschr. 129 (1-2): 31-35; January 2, 2004.

  36. Nokleby, H. [Vaccination of Persons With Allergy]. Tidsskr.Nor Laegeforen. 123 (23): 3400-3401; January 9, 2004.

  37. Parker, N. R. Positive Q Fever Skin Test After Vaccination. Med.J.Aust. 180 (1): 45-46; January 5, 2004.

  38. Poccia, F.; Gioia, C.; Montesano, C.; Martini, F.; Horejsh, D.; Castilletti, C.; Pucillo, L.; Capobianchi, M. R.; Ippolito, G. Flow Cytometry and T-Cell Response Monitoring After Smallpox Vaccination. Emerg.Infect.Dis. 9 (11): 1468-1470; November, 2003.

  39. Polk, B. [Who Should Get an Influenza Vaccination?]. Med.Monatsschr.Pharm. 26 (12): 429; December, 2003.

  40. Postma, M. J.; Heijnen, M. L.; Beutels, P.; Jager, J. C. Pharmacoeconomics of Elderly Vaccination Against Invasive Pneumococcal Infections: Cost-Effectiveness Analyses and Implications for The Netherlands. Expert.Rev.Vaccines. 2 (4): 477-482; August, 2003.

  41. Premenko-Lanier, M.; Rota, P.; Rhodes, G.; Bellini, W.; McChesney, M. Prior DNA Vaccination Does Not Interfere With the Live-Attenuated Measles Vaccine. Vaccine. 22 (5-6): 763-766; January 26, 2004.

  42. Puig-Barbera, J. [Vaccinations and Pregnancy (I): Vaccines That Are Indicated for Pregnant Women]. Aten.Primaria. 33 (1): 38-43; January, 2004.

  43. Sankar, P.; Schairer, C.; Coffin, S. Public Mistrust: The Unrecognized Risk of the CDC Smallpox Vaccination Program. Am.J.Bioeth. 3 (4): 22-25; 2003.

  44. Shapiro, Y.; Shemer, J.; Heymann, A.; Shalev, V.; Maharshak, N.; Chodik, G.; Green, M. S.; Kokia, E. Influenza Vaccination: Reduction in Hospitalizations and Death Rates Among Members of "Maccabi Healthcare Services" During the 2000-2001 Influenza Season. Isr.Med.Assoc.J. 5 (10): 706-708; October, 2003.

  45. Sipetic, S.; Vlajinac, H.; Kocev, N.; Radmanovic, S.  The Belgrade Childhood Diabetes Study: Association of Infections and Vaccinations on Diabetes in Childhood. Ann.Epidemiol. 13 (9): 645-651; October, 2003.

  46. Sleigh, K. M.; Marra, F. H.; Stiver, H. G. Influenza Vaccination: Is It Appropriate in Chronic Fatigue Syndrome?   Am.J.Respir.Med. 1 (1): 3-9; 2002.

  47. Staszewski, V.; Boulinier, T. Vaccination: a Way to Address Questions in Behavioral and Population Ecology?   Trends Parasitol. 20 (1): 17-22; January, 2004.

  48. Sun, W.; Edelman, R.; Kanesa-Thasan, N.; Eckels, K. H.; Putnak, J. R.; King, A. D.; Houng, H. S.; Tang, D.; Scherer, J. M.; Hoke, C. H., Jr.; Innis, B. L. Vaccination of Human Volunteers With Monovalent and Tetravalent Live-Attenuated Dengue Vaccine Candidates. Am.J.Trop.Med.Hyg. 69 (6 Suppl): 24-31; December, 2003.

  49. Thiry, N.; Beutels, P.; Van Damme, P.; Van Doorslaer, E. Economic Evaluation of Varicella Vaccination Programmes: a Review of the Literature. The Authors' Reply. Pharmacoeconomics. 22 (2): 136-138; 2004.

  50. Tomar, R. P. Pulse Polio Immunization: a Need for More Inputs. Indian J.Pediatr. 70 (11): 930; November, 2003.

  51. Whitham, M.; Blannin, A. K. The Effect of Exercise Training on the Kinetics of the Antibody Response to Influenza Vaccination. J.Sports Sci. 21 (12): 991-1000; December, 2003.

  52. Zimmerman, R. K. Recommended Childhood and Adolescent Immunization Schedule, United States, January to June, 2004 and Update on Childhood Immunizations. Am.Fam.Physician. 69 (1): 206-211; January 1, 2004.

  53. Zweiman, B.; Rothenberg, M. E. Sisk Et Al. Cost-Effectiveness of Vaccination Against Invasive Pneumococcal Disease Among People 50 Through 64 Years of Age: Role of Comorbid Conditions and Race. Ann Intern Med 2003 17;138:960-8. J.Allergy Clin.Immunol. 113 (1): 186; January, 2004.

Back to Top